Skip to content
Open access

Clinical Variability and Genotype‐Driven Outcomes in CHRND‐Related Congenital Myasthenic Syndrome

Aug 2026 · European Journal of Neurology · Vol 33 · 0 citations · 19 references
Medicine

TL;DR

Comprehensive genetic testing, longitudinal phenotyping, and genotype‐informed management are essential for optimal diagnosis and care in this rare disorder and underscores the critical role of genotype in determining disease severity.

Abstract

Congenital myasthenic syndromes (CMS) caused by pathogenic variants in CHRND, encoding the δ‐subunit of the nicotinic acetylcholine receptor (AChR), are rare, and data on genotype–phenotype correlations and long‐term outcomes are limited.

Read PDF

Similar papers

Review Aug 2026

Congenital myasthenic syndromes in Türkiye: genetic and clinical spectrum revisited in a nationwide pediatric cohort.

The results highlight the major contribution of a limited number of genes and underscore the importance of early molecular diagnosis in a population with high consanguinity and underscore the importance of early molecular diagnosis in a population with high consanguinity.

Canan Üstün, Ipek Polat, Gülten Öztürk et al. · 0 citations
Open access Aug 2026

First Korean Case of DOK7 Congenital Myasthenic Syndrome Responsive to Ephedrine Therapy

The first Korean case of tyrosine kinase 7 CMS with a favorable therapeutic response to ephedrine is reported, emphasizing the need to consider CMS in the differential diagnosis of congenital myopathy.

Sangwon Joe, M. Choi, Yunjung Choi et al. · 0 citations
Review Open access Aug 2026

Molecular and clinical heterogeneity in an Iranian case series of Joubert syndrome

This study expands the mutational landscape of JS in the Iranian population and underscores the utility of WES as a first-tier diagnostic tool for JS and related ciliopathies.

Sheyda Khalilian, Mohadeseh Fathi, Zahra Farbood et al. · 0 citations
Sep 2026

Allgrove syndrome in Colombia: clinical characterization and evidence of a possible founder effect

A highly prevalent AAAS variant suggestive of a possible founder effect was identified in the Paisa population and expanded the phenotypic spectrum and underscore the importance of early genetic testing and systematic multidisciplinary surveillance.

Johana Andrea Botero Hernandez, Eder Donadoni Varela Macias, María Victoria Lopera Cañaveral et al. · 0 citations
Review Open access Sep 2026

Pragmatic Phenotype–Electrophysiology–Genomics Integration in Pediatric Congenital Myasthenic Syndromes: Insights From 36 Patients in a Single‐Center Study in China

Pediatric CMS shows marked genetic heterogeneity and frequent VUS‐related uncertainty and Integrating phenotype, electrophysiology, and genomics supports diagnosis and mechanism‐guided therapy.

Li-Ya Cui, Kai-Yue Ma, Xiao-Na Fu et al. · 0 citations
Open access Aug 2026

Clinical and Genetic Profile of One Molecularly Confirmed and One Clinically Suspected Case of LZTR1 ‐Related Noonan Syndrome

Two unrelated female pediatric patients evaluated for LZTR1‐related NS following whole‐exome sequencing are reported to illustrate the marked phenotypic variability of LZTR1‐related NS and underscore that, while cardiac defects may be absent in some individuals, appropriate cardiac surveillance remains necessary.

Karolina J. Skrzynska, B. Kalina-Faska, Ewa Błaszczyk et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.